Inhibition of PDEδ by deltarasin in human KRAS-mutant pancreatic cancer cell lines blocks the localization of KRAS to the plasma membrane and impairs their proliferative capacity [69]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.